← FDA DRUG APPROVALS

FDA ANDA · ANDA076114

INDOMETHACIN

Sponsor: ABLE

APPLICATION
ANDA076114
TYPE
ANDA
ORIGINAL APPROVAL
2002-02-06
LATEST ACTION
2002-11-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

INDOMETHACINDiscontinued
INDOMETHACIN 75MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

2002-11-08Labeling · Supplement 4AP
2002-11-08Manufacturing (CMC) · Supplement 2AP
2002-11-08Manufacturing (CMC) · Supplement 5AP
2002-11-08Manufacturing (CMC) · Supplement 3AP
2002-08-19Manufacturing (CMC) · Supplement 1AP
2002-02-06OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →